Skip to content
★ Sign in to follow
PK

Peter K. Watler

Coherus Oncology, Inc.
Total declarations
20
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€4.8M

Latest filing published 19 Dec 2017 for Coherus Oncology, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

Peter K. Watler: trading record in brief

All filings by Peter K. Watler on record concern Coherus Oncology, Inc. We count 20 filings; the first trade dates from 20 November 2015 and the latest from 15 December 2017.

The open-market record consists of 10 sales worth €4.8M, with no purchase. The rest of the record consists of 1 share grant and 9 option exercises.

The newest entry dates from 19 December 2017: a share grant, in Coherus Oncology, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Peter K. Watler

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ◆
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    0SEC
    5,900 shares0Common Stock, $0.0001 par valueSEC:0000899243-17-029151:0
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    1M USD0SEC
    40,000 shares@ US$30.00Common Stock, $0.0001 par valueSEC:0000899243-16-026739:1
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    468,630 USD0SEC
    15,621 shares@ US$30.00Common Stock, $0.0001 par valueSEC:0000899243-16-026739:3
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    83,200 USD13SEC
    40,000 shares@ US$2.0820.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-026739:0
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    39,053 USD12SEC
    15,621 shares@ US$2.509.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-026739:2
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    85,731 USD0SEC
    3,291 shares@ US$26.05Common Stock, $0.0001 par valueSEC:0000899243-16-025639:1
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    18,536 USD0SEC
    700 shares@ US$26.48Common Stock, $0.0001 par valueSEC:0000899243-16-025639:2
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    8,301 USD11SEC
    3,991 shares@ US$2.082.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-025639:0
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    1M USD0SEC
    50,000 shares@ US$25.02Common Stock, $0.0001 par valueSEC:0000899243-16-025570:1
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    593,525 USD0SEC
    23,741 shares@ US$25.00Common Stock, $0.0001 par valueSEC:0000899243-16-025570:3
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    104,000 USD14SEC
    50,000 shares@ US$2.0825.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-025570:0
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    33,712 USD12SEC
    23,741 shares@ US$1.428.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-025570:2
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    870,770 USD0SEC
    43,495 shares@ US$20.02Common Stock, $0.0001 par valueSEC:0000899243-16-025043:1
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    90,470 USD13SEC
    43,495 shares@ US$2.0821.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-025043:0
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    240,000 USD0SEC
    12,000 shares@ US$20.00Common Stock, $0.0001 par valueSEC:0000899243-16-020411:1
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    24,960 USD12SEC
    12,000 shares@ US$2.085.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-020411:0
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    548,200 USD0SEC
    20,000 shares@ US$27.41Common Stock, $0.0001 par valueSEC:0000899243-16-019192:1
  • ▼
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    29,860 USD0SEC
    1,493 shares@ US$20.00Common Stock, $0.0001 par valueSEC:0000899243-16-019192:3
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    28,400 USD12SEC
    20,000 shares@ US$1.426.6% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-019192:0
  • ◇
    Chief Technical OfficerExecutivesCoherus Oncology, Inc.
    3,105 USD11SEC
    1,493 shares@ US$2.080.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-019192:2

20 of 20 declarations